$199.00
Ozempic is indicated to reduce the risk of major cardiovascular events in patients with type 2 diabetes and high cardiovascular risk as an adjunct to standard cardiovascular treatment.
Semaglutide reduces total body weight and fat mass by decreasing energy intake. This mechanism involves a general reduction in appetite, including increased satiety signals and decreased hunger signals, as well as improved control of food intake and decreased food cravings. Insulin resistance is also reduced, possibly through weight loss. Semaglutide also reduces the preference for high-fat foods. Animal studies have shown that semaglutide is taken up by specific areas of the brain and enhances key satiety signals and reduces key hunger signals. By acting on isolated areas of brain tissue, semaglutide activates neurons associated with satiety and suppresses neurons associated with hunger.
In clinical studies, semaglutide had a positive effect on plasma lipids, reduced systolic blood pressure and reduced inflammation.
Active ingredient: semaglutide
Prescription drug
Storage temperature 2-8 degrees
| Дозировка | 0,5 Mg, 1.0 Mg |
|---|
